Showing 331-340 of 3039 results for "".
COLLAB CORNER - Recognizing the Red Flags of Keratoconus
https://modernod.com/podcasts/collaborative-corner-the-podcast/recognizing-the-red-flags-of-keratoconus/36876/Marc R. Bloomenstein, OD, FAAO, invites John Gelles, OD, FAAO, FIAO, FCLSA, to review risk factors and red flags that all optometrists should know for detecting the early signs of keratoconus. Dr. Gelles shares insights from a study on pediatric keratoconus and highlights the importance of screeningGlaucoma + Quality of Life • MIGS Comanagement
https://modernod.com/podcasts/the-mod-pod/glaucoma-quality-of-life-migs-comanagement/36872/On this month's episode of The MOD Pod, hear Justin Schweitzer, OD, FAAO, talk to host Cecelia Koetting, OD, FAAO, Dipl ABO, about treatment compliance and ocular surface disease in patients with glaucoma. Also in this episode, Dr. Koetting invites Nora Lee Cothran, OD, FAAO, to discuss the differenBuilding Momentum in Your Contact Lens Business
https://modernod.com/podcasts/the-mod-pod/building-momentum-in-your-contact-lens-business/36871/Darryl Glover Jr., OD; Britt E. Gustafson, OD; and Selina R. McGee, OD, FAAO, discuss contact lenses as an integral pillar of their practice success. They review how technology, such as Alcon’s WaterInnovations™ portfolio, helps them differentiate their practice from competitors by customizing fitOSD’s Greatest Hits: 2024 Edition
https://modernod.com/podcasts/to-the-point/osds-greatest-hits-2024-edition/36942/In this month’s episode of To the Point, Jackie Garlich, OD, FAAO, and Cecelia Koetting, OD, FAAO, Dipl ABO, talk about the most exciting, important, and novel ocular surface disease (OSD) news to come out of the past year, including FDA approvals, product launches, new clinical data, and more. TheyWater-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/water-free-ciclosporin-based-eye-drop-for-ded-approved-in-europe/37052/Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.Weekly Headlines: Rayner Unveils First AI-Designed Spiral IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-08282024/37047/Rayner Unveils First AI-Designed Spiral IOL • Visionix Launches VX 610 Non-Mydriatic Automated Fundus Camera • Injectsense Completes First Human Implant of Ultraminiature IOP SensorUnderstanding the Neurobiology and Pain Pathways of DED
https://modernod.com/topics/ocular-surface/understanding-the-neurobiology-and-pain-pathways-of-ded/38836/A refresher on the basics.What’s New in Dry Eye Management?
https://modernod.com/topics/ocular-surface/whats-new-in-dry-eye-management/38765/A look at our growing list of options.76. A Holistic Approach to Dry Eye Disease ft. Dr. Mila Ioussifova
https://modernod.com/podcasts/four-eyes/76-a-holistic-approach-to-dry-eye-disease-ft-dr-mila-ioussifova/37026/Join Dr. Bilkhu in her discussion with Dr. Mila Ioussifova about taking a holistic approach to dry eye disease. Dr. Ioussifova is a residency-trained optometrist with a private practice in Portland, OR. She is dedicated to helping patients with dry eye disease and offers advanced dry eye therapies iUnderstanding the Genetics Behind Glaucoma
https://modernod.com/topics/glaucoma/understanding-the-genetics-behind-glaucoma/38741/The prevalence of different disease subtypes varies by ethnicity, suggesting a potential genetic component at play.